Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patricia Vella Bonanno

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|November 7, 2024
Implementation of Computerized Prescriber Order Entry Systems: A Review of Impacts, Barriers, and FacilitatorsIan Farrugia, Patricia Vella Bonanno
Frontiers in Pharmacology|December 6, 2021
A Review of the Evidence on Attitudes, Perceived Impacts and Motivational Factors for European Member State Collaboration for Pricing and Reimbursement of Medicines: Time for the EEA Member States to Apply Their Experience and Expertise in Evidence-Based Decision Making to Their Current Pharmaceutical Policy ChallengesPatricia Vella Bonanno, Vincent Cassar, Brian Godman
Pharmacology Research & Perspectives|April 17, 2025
Risk Management of Medication Errors: Improving the Quality of Pharmacotherapeutic PracticeRichard Anthony Despott, Patricia Vella Bonanno, Charmaine Gauci
Frontiers in Medical Technology|July 1, 2024
Ethical considerations in the regulation and use of herbal medicines in the European UnionAnthony Raphael Gatt, Patricia Vella Bonanno, Raymond Zammit
The International Journal of Risk & Safety in Medicine|February 28, 2013
Medication errors through a national pharmacovigilance database approach: a study for MaltaAmy Tanti, Miriam Camilleri, Patricia Vella Bonanno, et al.
Research in Social & Administrative Pharmacy : RSAP|July 18, 2019
Patients' lived experiences with antineoplastic medicines for the management of malignant solid tumours: A systematic reviewAlison Brincat, Patricia Vella Bonanno, Derek Stewart, et al.
International Journal of Clinical Pharmacy|August 23, 2025
Colorectal cancer patients' experiences with antineoplastic agents from the perspective of their significant others: a longitudinal qualitative studyAlison Brincat, Antonella Tonna, Patricia Vella Bonanno, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 8, 2009
Where is industry getting it wrong? A review of quality concerns raised at Day 120 by the Committee For Medicinal Products for Human Use during European Centralised Marketing Authorisation Submissions for Chemical Entity Medicinal ProductsJohn Joseph Borg, Jean-Louis Robert, George Wade, et al.
International Journal of Nursing Studies Advances|August 20, 2025
Patient safety and the second victim phenomenon in nursing and medical curricula: A qualitative studyEinav Srulovici, Mary-Elizabeth Tumelty, Ivana Meszaros Skoumalova, et al.
Frontiers in Pharmacology|July 22, 2022
Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European CountriesAlice Pisana, Björn Wettermark, Amanj Kurdi, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|November 7, 2024
Implementation of Computerized Prescriber Order Entry Systems: A Review of Impacts, Barriers, and FacilitatorsIan Farrugia, Patricia Vella Bonanno
Frontiers in Pharmacology|December 6, 2021
A Review of the Evidence on Attitudes, Perceived Impacts and Motivational Factors for European Member State Collaboration for Pricing and Reimbursement of Medicines: Time for the EEA Member States to Apply Their Experience and Expertise in Evidence-Based Decision Making to Their Current Pharmaceutical Policy ChallengesPatricia Vella Bonanno, Vincent Cassar, Brian Godman
Pharmacology Research & Perspectives|April 17, 2025
Risk Management of Medication Errors: Improving the Quality of Pharmacotherapeutic PracticeRichard Anthony Despott, Patricia Vella Bonanno, Charmaine Gauci
Frontiers in Medical Technology|July 1, 2024
Ethical considerations in the regulation and use of herbal medicines in the European UnionAnthony Raphael Gatt, Patricia Vella Bonanno, Raymond Zammit
The International Journal of Risk & Safety in Medicine|February 28, 2013
Medication errors through a national pharmacovigilance database approach: a study for MaltaAmy Tanti, Miriam Camilleri, Patricia Vella Bonanno, et al.
Research in Social & Administrative Pharmacy : RSAP|July 18, 2019
Patients' lived experiences with antineoplastic medicines for the management of malignant solid tumours: A systematic reviewAlison Brincat, Patricia Vella Bonanno, Derek Stewart, et al.
International Journal of Clinical Pharmacy|August 23, 2025
Colorectal cancer patients' experiences with antineoplastic agents from the perspective of their significant others: a longitudinal qualitative studyAlison Brincat, Antonella Tonna, Patricia Vella Bonanno, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|September 8, 2009
Where is industry getting it wrong? A review of quality concerns raised at Day 120 by the Committee For Medicinal Products for Human Use during European Centralised Marketing Authorisation Submissions for Chemical Entity Medicinal ProductsJohn Joseph Borg, Jean-Louis Robert, George Wade, et al.
International Journal of Nursing Studies Advances|August 20, 2025
Patient safety and the second victim phenomenon in nursing and medical curricula: A qualitative studyEinav Srulovici, Mary-Elizabeth Tumelty, Ivana Meszaros Skoumalova, et al.
Frontiers in Pharmacology|July 22, 2022
Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European CountriesAlice Pisana, Björn Wettermark, Amanj Kurdi, et al.
Pageof 3